Sponsored by stelo
Expanding Access to Glucose Monitoring for Proactive Metabolic Health
The expanding availability of continuous glucose monitoring (CGM) technology has introduced new opportunities for individuals beyond those with insulin-dependent diabetes. With the emergence of glucose biosensors that can be obtained without a prescription, more adults—including those with prediabetes or simply seeking to better understand their metabolic health—are gaining access to real-time glucose insights. This shift has important implications for both patients and providers, offering a new avenue for proactive, personalized care. Test your knowledge on this evolving landscape.
